Symptom Management for YA Cancer Survivors

计划入组 65 人 · 首次发布于 2019 年 7 月 29 日

Feasibility of SBIRT-PN

计划入组 86 人 · 首次发布于 2017 年 2 月 17 日

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

计划入组 120 人 · 首次发布于 2002 年 5 月 31 日

YA-2

YA-101

MDL-201-404YA

Meiragtx UK II Ltd.

Belgium

DIGITAL SERVICES AUSTRALIA II PTY LTD

Australia

Cisen Pharmaceutical Co., Ltd.(Zone-II)

China

FibroBiologics Secures $25M Equity Purchase Agreement to Advance Clinical Programs in Multiple Diseases

Kiromic BioPharma's Deltacel-01 Shows Promise in Solid Tumors, Faces Financial Hurdles

Predictive Oncology Secures $10M Equity Agreement to Advance AI-Driven Cancer Drug Discovery